NCT02345668

Brief Summary

The aim of this study is to assess the efficacy of a Transdiagnostic Internet-based Protocol (Emotion Regulation Protocol) for the treatment of unipolar mood disorders (major depression and dysthimia) four anxiety disorders (Panic disorder, agoraphobia, generalized anxiety disorder and social anxiety disorder) and obsessive-compulsive disorder in comparison with Treatment as Usual in specialized care (Spanish public mental health system).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
Completed

Started Apr 2015

Longer than P75 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 9, 2015

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 26, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2015

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

September 24, 2019

Status Verified

September 1, 2019

Enrollment Period

4.3 years

First QC Date

January 9, 2015

Last Update Submit

September 23, 2019

Conditions

Keywords

Transdiagnostic Internet-based ProtocolTreatment as Usual (TAU)

Outcome Measures

Primary Outcomes (2)

  • Change in the Beck Depression Inventory (BDI-II) (Beck, Steer, & Brown, 1990; Sanz, Navarro, & Vázquez, 2003) at pre, post intervention and at 3 and 12 months follow-ups.

    It is one of the most widely used questionnaires to evaluate depression severity in pharmacological and psychotherapy trials. It consists of 21 items about the different symptoms characterizing major depression disorder, added together to obtain the total score, which can be a maximum of 63 points. The instrument has good internal consistency (α = 0.76 to 0.95). The Spanish version of this instrument has also shown a high internal consistency (α = 0.87) for both the general and clinical populations (α = .89) are coded from 0 to 4, added together to obtain a total score ranging from 0 to 20. The Spanish version has shown shown good internal consistency (α = 0.86), and convergent and discriminant validity.

    Up to 12 months

  • Change in the Beck Anxiety Inventory (BAI) (Beck, & Steer, 1990; Magán, Sanz, & García-Vera, 2008) at pre, post intervention and at 3 and 12 months follow-ups.

    The BAI is a 21-item self-report measure designed to assess anxiety. Each item has a 4-point Severity scale (e.g., not at all, mildly, moderately, and severely) that addresses symptoms experienced during the past week. The internal consistency of the BAI has been found to range from .85 to .94.

    Up to 12 months

Secondary Outcomes (4)

  • Change in Obsessive-Compulsive Inventory (OCI-R) (Foa et al., 2002; Fullana et al., 2004) at pre, post intervention and at 3 and 12 months follow-ups.

    Up to 12 months

  • Change in the Self-Reported Panic Disorder Severity Scale (PDSS-SR) (Houck, Spiegel, Shear, & Rucci, 2002) at pre, post intervention and at 3 and 12 months follow-ups.

    Up to 12 months

  • Change in the Pen State Worry Questionnaire (PSWQ) (Meyer, Miller, Metzger, & Borkovec, 1990) at pre, post intervention and at 3 and 12 months follow-ups.

    Up to 12 months

  • Change in the Social Interaction Anxiety Inventory (SIAS) (Mattick y Clarke, 1998) at pre, post intervention and at 3 and 12 months follow-ups.

    Up to 12 months

Other Outcomes (2)

  • Change in the EuroQoL-5D (Badía, 1999) at pre, post intervention and at 3 and 12 months follow-ups.

    Up to 12 months

  • Client Service Receipt Inventory (CSRI) (Vázquez-Barquero et al., 1997) at pre, at 3 and 12 months follow-ups.

    Up to 12 months

Study Arms (2)

Transdiagnostic Internet-based Treatment

EXPERIMENTAL

Intervention group that carries out the Emotion Regulation Protocol and receives support by the therapist (a brief weekly two-minute phone call without clinical content and two weekly orientative text messages)

Behavioral: Emotion Regulation Protocol

Treatment as Usual

EXPERIMENTAL

Intervention group that receives psychological and/or pharmacological treatment from a clinician of the mental health unit.

Drug: Treatment as Usual (Pharmacological Treatment)Behavioral: Treatment as Usual (Psychological Treatment)

Interventions

Emotion Regulation Protocol is an Internet-based Self-administered Protocol for emotional disorders, which will allow the individual to learn and practice adaptive ways to regulate their emotions from a transdiagnostic perspective. The protocol contains the following components: present-focused emotional awareness, cognitive flexibility, emotional avoidance and emotion-driven behaviors, interoceptive and situation-based emotion exposure, psychoeducation about emotions, motivational enhancement and relapse prevention, which are organized in twelve modules: Emotional disorders and emotion regulation; Motivation for change; Understanding the role of emotions; The acceptance of emotional experiences; Practicing the acceptance; Learning to be flexible; Practicing the cognitive flexibility; The emotional avoidance; Emotion driven behaviors; Accepting and facing physical sensations; Facing emotions in the contexts in which they occur; and Relapse Prevention.

Transdiagnostic Internet-based Treatment

The Pharmacological Treatment provided by a psychiatrist in the mental health unit.

Treatment as Usual

The Psychological Treatment provided by a clinical psychologist in the mental health unit.

Treatment as Usual

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being aged between 18 and 70 years old.
  • Meeting the DSM-IV diagnosis criteria of emotional disorder (panic disorder with or without agoraphopia, social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder, major depression disorder and dysthimia).
  • Providing written, informed consent.
  • Being able to understand and read Spanish.
  • Having daily acces to the Internet in their natural environment.

You may not qualify if:

  • Being diagnosed a severe mental disorder (people with the following mental disorders will be excluded from the study: schizophrenia, bipolar disorder and personality disorders from clusters A and B).
  • Being diagnosed an alcohol and/or substance dependence disorder.
  • The presence of high suicidal risk.
  • A medical disease or condition which prevent the participant from carry out the psychological treatment.
  • Receiving another psychological treatment while the study is still ongoing.
  • The increase and/or changes in the medication of participants receiving pharmacological treament during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Jaume I

Castellon, Castellón, 12071, Spain

Location

Related Publications (6)

  • Titov N, Andrews G, Johnston L, Robinson E, Spence J. Transdiagnostic Internet treatment for anxiety disorders: A randomized controlled trial. Behav Res Ther. 2010 Sep;48(9):890-9. doi: 10.1016/j.brat.2010.05.014. Epub 2010 May 24.

    PMID: 20561606BACKGROUND
  • Titov N, Dear BF, Schwencke G, Andrews G, Johnston L, Craske MG, McEvoy P. Transdiagnostic internet treatment for anxiety and depression: a randomised controlled trial. Behav Res Ther. 2011 Aug;49(8):441-52. doi: 10.1016/j.brat.2011.03.007. Epub 2011 Apr 3.

    PMID: 21679925BACKGROUND
  • Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, Gallagher MW, Barlow DH. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Ther. 2012 Sep;43(3):666-78. doi: 10.1016/j.beth.2012.01.001. Epub 2012 Jan 18.

    PMID: 22697453BACKGROUND
  • Gonzalez-Robles A, Roca P, Diaz-Garcia A, Garcia-Palacios A, Botella C. Long-term Effectiveness and Predictors of Transdiagnostic Internet-Delivered Cognitive Behavioral Therapy for Emotional Disorders in Specialized Care: Secondary Analysis of a Randomized Controlled Trial. JMIR Ment Health. 2022 Oct 31;9(10):e40268. doi: 10.2196/40268.

  • Gonzalez-Robles A, Diaz-Garcia A, Garcia-Palacios A, Roca P, Ramos-Quiroga JA, Botella C. Effectiveness of a Transdiagnostic Guided Internet-Delivered Protocol for Emotional Disorders Versus Treatment as Usual in Specialized Care: Randomized Controlled Trial. J Med Internet Res. 2020 Jul 7;22(7):e18220. doi: 10.2196/18220.

  • Gonzalez-Robles A, Garcia-Palacios A, Banos R, Riera A, Llorca G, Traver F, Haro G, Palop V, Lera G, Romeu JE, Botella C. Effectiveness of a transdiagnostic internet-based protocol for the treatment of emotional disorders versus treatment as usual in specialized care: study protocol for a randomized controlled trial. Trials. 2015 Oct 31;16:488. doi: 10.1186/s13063-015-1024-3.

Related Links

MeSH Terms

Conditions

Anxiety DisordersDepression

Interventions

TherapeuticsDrug Therapy

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Cristina Botella, Professor

    University Jaume I, Castellon, Spain

    STUDY DIRECTOR
  • Azucena García-Palacios, Professor

    University Jaume I, Castellon, Spain

    STUDY DIRECTOR
  • Francisco Traver

    Consorcio Hospitalario Provincial de Castellón, Spain

    STUDY CHAIR
  • Gonzalo Haro

    Consorcio Hospitalario Provincial de Castellón, Spain

    STUDY CHAIR
  • Ginés Llorca

    Consorcio Hospitalario Provincial de Castellón, Spain

    STUDY CHAIR
  • Alberto Gonzalez-Robles, PhD Student

    University Jaume I, Castellon, Spain

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2015

First Posted

January 26, 2015

Study Start

April 1, 2015

Primary Completion

July 1, 2019

Study Completion

July 1, 2019

Last Updated

September 24, 2019

Record last verified: 2019-09

Locations